| Posterior musculofascial reconstruction after radical prostatectomy: an updated systematic review and a meta‐analysis AAC Grasso, FA Mistretta, M Sandri, G Cozzi, E De Lorenzis, M Rosso, ... BJU international 118 (1), 20-34, 2016 | 88 | 2016 |
| Radiomics in prostate cancer: An up-to-date review M Ferro, O de Cobelli, G Musi, F Del Giudice, G Carrieri, GM Busetto, ... Therapeutic Advances in Urology 14, 17562872221109020, 2022 | 74 | 2022 |
| Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2] proPSA (p2PSA),% p2PSA, and prostate health index in men with a total … M Lazzeri, A Abrate, G Lughezzani, GM Gadda, M Freschi, F Mistretta, ... Urology 83 (3), 606-612, 2014 | 64 | 2014 |
| Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses A Larcher, N Fossati, F Mistretta, G Lughezzani, G Lista, P Dell’Oglio, ... Urologic Oncology: Seminars and Original Investigations 33 (1), 22. e1-22. e9, 2015 | 62 | 2015 |
| Thulium laser treatment of upper urinary tract carcinoma: a multi-institutional analysis of surgical and oncological outcomes G Musi, FA Mistretta, C Marenghi, A Russo, M Catellani, S Nazzani, ... Journal of Endourology 32 (3), 257-263, 2018 | 54 | 2018 |
| Clinical performance of serum isoform [‐2] pro PSA (p2PSA), and its derivatives% p2PSA and the Prostate Health Index, in men aged< 60 years: results from a multicentric E … N Fossati, M Lazzeri, A Haese, T McNicholas, A de la Taille, NM Buffi, ... BJU international 115 (6), 913-920, 2015 | 51 | 2015 |
| Clinical use of [-2] proPSA (p2PSA) and its derivatives (% p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature A Abrate, G Lughezzani, GM Gadda, G Lista, E Kinzikeeva, N Fossati, ... Korean journal of urology 55 (7), 436-445, 2014 | 50 | 2014 |
| Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients M Ferro, G Musi, A Serino, G Cozzi, FA Mistretta, B Costa, R Bianchi, ... Urologia internationalis 102 (1), 43-50, 2019 | 48 | 2019 |
| Contemporary national assessment of robot-assisted surgery rates and total hospital charges for major surgical uro-oncological procedures in the United States E Mazzone, FA Mistretta, S Knipper, Z Tian, A Larcher, H Widmer, K Zorn, ... Journal of endourology 33 (6), 438-447, 2019 | 46 | 2019 |
| MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra … SG Gugliandolo, M Pepa, LJ Isaksson, G Marvaso, S Raimondi, F Botta, ... European Radiology 31, 716-728, 2021 | 40 | 2021 |
| In-hospital length of stay after major surgical oncological procedures S Nazzani, F Preisser, E Mazzone, Z Tian, FA Mistretta, SF Shariat, ... European Journal of Surgical Oncology 44 (7), 969-974, 2018 | 40 | 2018 |
| Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review M Ferro, F Crocetto, B Barone, F Del Giudice, M Maggi, G Lucarelli, ... Therapeutic Advances in Urology 15, 17562872231164803, 2023 | 38 | 2023 |
| Impact of age on outcomes of patients with pure carcinoma in situ of the bladder: multi-institutional cohort analysis M Ferro, S Chiujdea, G Musi, G Lucarelli, F Del Giudice, R Hurle, ... Clinical Genitourinary Cancer 20 (2), e166-e172, 2022 | 35 | 2022 |
| Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug target F Mistretta, NM Buffi, G Lughezzani, G Lista, A Larcher, N Fossati, ... BioMed research international 2014 (1), 987149, 2014 | 35 | 2014 |
| Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre E uropean … A Abrate, M Lazzeri, G Lughezzani, N Buffi, V Bini, A Haese, A de la Taille, ... BJU international 115 (4), 537-545, 2015 | 32 | 2015 |
| Contemporary comparison of clinicopathologic characteristics and survival outcomes of prostate ductal carcinoma and acinar adenocarcinoma: a population-based study S Knipper, F Preisser, E Mazzone, FA Mistretta, Z Tian, A Briganti, ... Clinical genitourinary cancer 17 (3), 231-237. e2, 2019 | 31 | 2019 |
| Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer M Ferro, B Barone, F Crocetto, G Lucarelli, GM Busetto, F Del Giudice, ... Urologic Oncology: Seminars and Original Investigations 40 (11), 490. e13 …, 2022 | 30 | 2022 |
| Multiparametric magnetic resonance imaging second opinion may reduce the number of unnecessary prostate biopsies: time to improve radiologists’ training program? S Luzzago, G Petralia, G Musi, M Catellani, S Alessi, E Di Trapani, ... Clinical Genitourinary Cancer 17 (2), 88-96, 2019 | 29 | 2019 |
| Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer M Ferro, G Di Lorenzo, C Buonerba, G Lucarelli, GI Russo, F Cantiello, ... Journal of cancer 9 (22), 4250, 2018 | 29 | 2018 |
| Robot-assisted partial nephrectomy: 5-yr oncological outcomes at a single European tertiary cancer center MD Vartolomei, DV Matei, G Renne, VM Tringali, N Crisan, G Musi, ... European Urology Focus 5 (4), 636-641, 2019 | 28 | 2019 |
